Efficacy of Splenectomy in Treating Refractory Autoimmune Hemolytic Anemia Linked to Systemic Lupus Erythematosus: A Case Study with Mechanistic Analysis - Top-Institutions - MDSpire

Efficacy of Splenectomy in Treating Refractory Autoimmune Hemolytic Anemia Linked to Systemic Lupus Erythematosus: A Case Study with Mechanistic Analysis

  • By

  • Xiaoli Pan

  • Juan Chen

  • Chunyan Li

  • Yupei Lin

  • Yu Wang

  • Jingqiao Tian

  • Mei Tian

  • Anmao Li

  • April 28, 2026

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology
    • Rheumatology
    • Immunology

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Hematology
    • Rheumatology
    • Immunology

  • #3

    University of Pennsylvania (Perelman School of Medicine)
    University of Pennsylvania (Perelman School of Medicine)

    Philadelphia, PA

    Key Differentiators

    • Hematology
    • Rheumatology
    • Immunology

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Hematology
    • Rheumatology
    • Immunology

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Hematology
    • Rheumatology
    • Immunology

Original Source(s)

Efficacy of Splenectomy in Treating Refractory Autoimmune Hemolytic Anemia Linked to Systemic Lupus Erythematosus: A Case Study with Mechanistic Analysis

  • by Xiaoli Pan, Juan Chen, Chunyan Li, Yupei Lin, Yu Wang, Jingqiao Tian, Mei Tian, Anmao Li

  • April 28, 2026

Related Content

Connective tissue diseases combined with chronic myelomonocytic leukemia and myelofibrosis: a case report and literature review

Research advances in connective tissue disease-associated pulmonary arterial hypertension with an emphasis on the Chinese population

Immune regulation and cell metabolism in B cell subsets in patients with systemic lupus erythematosus